6431.TW TAI
Kuangli Bio-Tech Holdings Co., Ltd.
1W: -2.3%
1M: -13.0%
3M: -13.0%
YTD: -34.7%
1Y: +8.6%
3Y: -11.7%
5Y: -49.3%
NT$16.90 ($0.53)
-0.15 (-0.88%)
Weekly Expected Move ±4.1%
NT$16
NT$16
NT$17
NT$18
NT$18
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$145M
-122.8% ▼
Capital Expenditures
$9M
+47.6% ▲
5Y CAGR: +1.5%
Free Cash Flow
-$154M
-86.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$167M
+873.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $50M | -$85M | -$104M | -$182M | -$193M |
| Depreciation & Amort. | $40M | $61M | $61M | $84M | $87M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $14M | $12M | -$8M | -$4M | -$65M |
| Other Non-Cash Items | -$82M | $3M | -$11M | $37M | $26M |
| Operating Cash Flow | $22M | -$9M | -$62M | -$65M | -$145M |
| — Investing Activities — | |||||
| Capital Expenditures | -$41M | -$34M | -$25M | -$12M | -$9M |
| Acquisitions (Net) | -$61M | -$1M | $0 | $0 | $0 |
| Investment Purchases | -$4M | $0 | -$28M | $0 | -$3M |
| Investment Sales | $7M | $0 | $21M | $28M | $0 |
| Other Investing | $5M | $32M | $1M | $47M | $26M |
| Investing Cash Flow | -$93M | -$3M | -$31M | $62M | $14M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$4M | $21M | $42M | -$40M | $20M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$20M | -$385M | -$25M | -$31M | -$26M |
| Financing Cash Flow | $121M | -$11M | $18M | -$16M | $314M |
| Net Change in Cash | $48M | -$20M | -$79M | -$22M | $167M |
| Cash End of Period | $162M | $142M | $63M | $42M | $209M |
| Free Cash Flow | -$19M | -$43M | -$88M | -$83M | -$154M |